All News about Astrazeneca Plc ADR![]() Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
AstraZeneca Strikes Deal With Absci To Leverage AI In Cancer Drug Discovery: Report
December 04, 2023
Via Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
![]() ![]() ![]() ![]()
AstraZeneca advances scientific leadership in hematology at ASH 2023
November 29, 2023
From AstraZeneca
Via Business Wire
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
FDA Approves AstraZeneca's Truqap/Faslodex Combo Therapy For Breast Cancer, Competes With Gilead's Drug
November 17, 2023
Via Benzinga
Exposures
Product Safety
![]() ![]() ![]()
Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyes $200 Billion GLP-1 Market with its DehydraTECH(TM) Technology
November 14, 2023
Via CannabisNewsWire
Topics
Intellectual Property
Exposures
Intellectual Property
![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|